[ad_1] First Application of MAP technology in humans to drive regenerative biologic response and spare scarring SAN DIEGO, Sept. 5, 2024 /PRNewswire/ — Tempo Therapeutics, Inc. (“Tempo”), a leading innovator in tissue engineering and regenerative […]
